Page last updated: 2024-08-18

diphenyl and Acute Confusional Senile Dementia

diphenyl has been researched along with Acute Confusional Senile Dementia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Alpan, AS; Alptuzun, V; Fidan, GS; Parlar, S; Tarikogullari, AH1
Aramati, BMR; Damu, AG; Jeelan Basha, S; Kumar, S; Monika, K; Naidu Gajula, N; Sivakumar, I; Subramanyam, R; Vadde, R; Yelamanda Rao, K1
Du, GH; Feng, B; Fu, H; Liu, AL; Wang, DM; Wang, L; Wu, S1

Other Studies

3 other study(ies) available for diphenyl and Acute Confusional Senile Dementia

ArticleYear
Design, synthesis, acetylcholinesterase, butyrylcholinesterase, and amyloid-β aggregation inhibition studies of substituted 4,4'-diimine/4,4'-diazobiphenyl derivatives.
    Archiv der Pharmazie, 2022, Volume: 355, Issue:12

    Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Butyrylcholinesterase; Cholinesterase Inhibitors; Humans; Molecular Docking Simulation; Structure-Activity Relationship

2022
Development of quinazolinone and vanillin acrylamide hybrids as multi-target directed ligands against Alzheimer's disease and mechanistic insights into their binding with acetylcholinesterase.
    Journal of biomolecular structure & dynamics, 2023, Volume: 41, Issue:20

    Topics: Acetylcholinesterase; Acrylamide; Alzheimer Disease; Amyloid beta-Peptides; Butyrylcholinesterase; Cholinesterase Inhibitors; Humans; Hydrogen Peroxide; Kinetics; Ligands; Molecular Docking Simulation; Structure-Activity Relationship

2023
Design, Synthesis, and Biological Evaluation of a New Series of Biphenyl/Bibenzyl Derivatives Functioning as Dual Inhibitors of Acetylcholinesterase and Butyrylcholinesterase.
    Molecules (Basel, Switzerland), 2017, Jan-20, Volume: 22, Issue:1

    Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Bibenzyls; Biphenyl Compounds; Butyrylcholinesterase; Cholinesterase Inhibitors; Drug Design; Humans; Molecular Docking Simulation; Rats; Structure-Activity Relationship

2017